Skip to main content
Caplight Logo









Vilje Bionics

Vilje Bionics

Private
OsloHealthcare & Life Scienceshttps://viljebionics.com/

Last Round

Seed

Sep 22, 2025

Total Funding Raised

$1.95M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Vilje Bionics is a medical technology company that develops a motorized exoskeleton for the entire arm, designed to help people with reduced mobility regain function.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Sensors, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

assistive exoskeletonfull-arm exoskeletonrobotic exoskeletonstroke rehabilitationmedical deviceneurological rehabilitationrehabilitation roboticsassistive technologymotorized orthosismedical roboticsbionic armmedtechrehab techwearable robotorthoticsintent decodingwearable technology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vilje Bionics Comparables

Compare Vilje Bionics with similar companies based on industry and business-model similarity.

Vilje Bionics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Roceso Technologies
77%
Myomo Inc
75%
Focal Meditech BV
71%

Vilje Bionics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 22, 2025

Key People

Founding team and executive leadership

Maren Kirknes Fossum

Co-Founder & Chief Operating Officer (COO) & Quality Assurance Manager

Founding Team

Saeid Hosseini

Co-Founder and CEO

Founding Team

Eirik Bodsberg

CTO

Executive Team

Vilje Bionics Investors

Notable investors and investment history

Vilje Bionics investors
InvestorRounds
Innovasjon NorgeSeed
MP PensjonSeed
Nordic IgniteSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 6, 2025

    Monthly visitors grew 477% MoM, reaching 4K.

  • Sep 22, 2025

    $1.95M round with investors including Innovasjon Norge and Nordic Ignite.

Vilje Bionics Filings

Explore SEC and related filing metadata, where available.

Vilje Bionics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Vilje Bionics's valuation, stock price, and market status.

Is Vilje Bionics a public or private company?

Vilje Bionics is a private company.

What is the current stock price of Vilje Bionics?

Vilje Bionics is a private company with no public stock price. No recent secondary market data is available.

How much is Vilje Bionics worth (valuation)?

Valuation information for Vilje Bionics is not publicly available.

Can I buy Vilje Bionics stock?

Vilje Bionics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Vilje Bionics's last funding round?

Funding round information for Vilje Bionics is not publicly available.

Who are the main investors in Vilje Bionics?

Investor information for Vilje Bionics is not publicly disclosed.

Will Vilje Bionics IPO soon?

No public IPO plans have been announced for Vilje Bionics.

How can I track Vilje Bionics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vilje Bionics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOslo
Employee Range8
Year Founded2020
Last FundingSep 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?